Cargando…
Peptide Nanomedicines for Treatment of Acute Lung Injury
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a heterogenous group of lung disease in critically ill patients. Despite the increased understanding of the molecular pathogenesis of ARDS, the mortality remains unacceptably high, ranging from 34% to 64%. Hence, ARDS r...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149708/ https://www.ncbi.nlm.nih.gov/pubmed/22449933 http://dx.doi.org/10.1016/B978-0-12-391860-4.00016-1 |